Condition
Allergy Drug
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Terminated1
Completed1
Recruiting1
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07194824Not ApplicableTerminatedPrimary
A Penicillin Allergy Delabeling Inhospital Model Hospitalized Patients
NCT05670756CompletedPrimary
Preoperative Survey to Evaluate Patient Allergy
NCT06167564Not ApplicableUnknown
Allergy Diagnostic Test Based on Microchip Technology
NCT03581604Not ApplicableRecruitingPrimary
De-labeling of Patients With False Diagnosis of Penicillin Allergy
Showing all 4 trials